Exploration of dose and schedule of administration in an expanded Phase 2 trial with ...
NEW YORK, March 16, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional ...
Company announcement - No. 20 / 2018 Zealand Pharma - Interim report for ...
